Advertising of contrast material: A developing problem

R. L. Siegle

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Problems exist when indications for the use of new contrast agents and new indications for the use of conventional contrast agents are considered in relation to advertisements. Ultimately, the consumer pays the cost of expensive FDA testing, often to prove what is already obvious. Other medically indicated uses of a contrast agent may remain unapproved because there is no financial incentive to seek approval, and needed modifications in already approved advertisements may not be sought for the same reason. A cooperative effort among manufacturers, radiologists, and the FDA is needed to improve the process.

Original languageEnglish (US)
Pages (from-to)261-262
Number of pages2
JournalRadiology
Volume153
Issue number1
DOIs
StatePublished - 1984

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Advertising of contrast material: A developing problem'. Together they form a unique fingerprint.

Cite this